Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
1.220
-0.060 (-4.69%)
At close: Mar 9, 2026, 4:00 PM EDT
1.220
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:26 PM EDT
Bone Biologics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -3.11 | -4.11 | -8.95 | -1.48 | -1.61 | |
| Stock-Based Compensation | 0.26 | 0.19 | 0.15 | 0.27 | 0.21 | |
| Other Operating Activities | -0 | -0.05 | -0.89 | -2.18 | 0.5 | |
| Change in Accounts Payable | 0.09 | 0.09 | 0.26 | 0 | -0.37 | |
| Change in Unearned Revenue | - | - | -0.78 | 0.78 | - | |
| Change in Other Net Operating Assets | 0.07 | -0.24 | 0.66 | -0.96 | 0.05 | |
| Operating Cash Flow | -2.69 | -4.12 | -9.56 | -3.57 | -1.23 | |
| Long-Term Debt Issued | - | - | - | - | 1.06 | |
| Total Debt Issued | - | - | - | - | 1.06 | |
| Short-Term Debt Repaid | - | - | - | - | -0.01 | |
| Total Debt Repaid | - | - | - | - | -0.01 | |
| Net Debt Issued (Repaid) | - | - | - | - | 1.05 | |
| Issuance of Common Stock | 4.7 | 4.42 | 5.04 | 4.43 | 6.86 | |
| Financing Cash Flow | 4.7 | 4.42 | 5.04 | 4.43 | 7.9 | |
| Net Cash Flow | 2.01 | 0.3 | -4.51 | 0.86 | 6.68 | |
| Free Cash Flow | -2.69 | -4.12 | -9.56 | -3.57 | -1.23 | |
| Free Cash Flow Per Share | -2.29 | -16.31 | -217.89 | - | - | |
| Cash Interest Paid | - | - | - | - | 0.01 | |
| Levered Free Cash Flow | -1.65 | -2.73 | -7.21 | -0.99 | - | |
| Unlevered Free Cash Flow | -1.65 | -2.73 | -7.21 | -0.53 | - | |
| Change in Working Capital | 0.17 | -0.15 | 0.13 | -0.17 | -0.32 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.